Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 2—February 2018

Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection

Tim R.H. ReadComments to Author , Jørgen S. Jensen, Christopher K. Fairley, Mieken Grant, Jennifer A. Danielewski, Jenny Su, Gerald L. Murray, Eric P.F. Chow, Karen Worthington, Suzanne M. Garland, Sepehr N. Tabrizi, and Catriona S. Bradshaw
Author affiliations: Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia (T.R.H. Read, C.K. Fairley, M. Grant, E.P.F. Chow, K. Worthington, C.S. Bradshaw); Monash University, Melbourne, Victoria, Australia (T.R.H. Read, C.K. Fairley, G.L. Murray, E.P.F. Chow, C.S. Bradshaw); Statens Serum Institut, Copenhagen, Denmark (J.S. Jensen); Murdoch Children’s Research Institute, Parkville, Victoria, Australia (J.A. Danielewski, J. Su, G.L. Murray, S.M. Garland, S.N. Tabrizi); Royal Women’s Hospital, Parkville (J.A. Danielewski, J. Su, G.L. Murray, S.M. Garland, S.N. Tabrizi); University of Melbourne, Parkville (S.M. Garland, S.N. Tabrizi, C.S. Bradshaw)

Main Article

Table 1

Characteristics of patients with Mycoplasma genitalium infections treated with pristinamycin, Melbourne Sexual Health Centre, Melbourne, Victoria, Australia, 2012–2016

Characteristic Men who have sex with men, n = 65 Heterosexual men, n = 38 Female, n = 11
Median age, y (interquartile range)
32.0 (27.4–37.3)
27.9 (24.6–34.6)
26.1 (22.6–28.2)
Sample, no.
Urine* 39 38 6
Rectal swab 26 0 2
Cervical swab
Not applicable
Not applicable
Diagnosis, no.†
Nongonococcal urethritis 37 33
Proctitis 8 0 0
Pelvic inflammatory disease 2
Asymptomatic, no. 11 2 3

*Includes 1 urethral swab sample.
†Clinical diagnosis when first tested for M. genitalium.
‡Comprises urethral gonorrhea (n = 3), anal discharge (n = 3), other anal symptoms (n = 3), female dysuria (n = 2), vaginal discharge (n = 2), vaginal bleeding (n = 2), not recorded (n = 3).

Main Article

Page created: January 17, 2018
Page updated: January 17, 2018
Page reviewed: January 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.